MEIP - MEI Pharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue23,249--
Cost of Revenue5,000--
Gross Profit18,249--
Operating Expenses
Research Development7,23713,40323,823
Selling General and Administrative8,6287,6018,948
Non Recurring---
Total Operating Expenses---
Operating Income or Loss2,384-21,004-32,771
Income from Continuing Operations
Total Other Income/Expenses Net28714378
Earnings Before Interest and Taxes2,671-20,861-32,693
Interest Expense---
Income Before Tax2,671-20,861-32,693
Income Tax Expense111
Minority Interest---
Net Income From Continuing Ops2,670-20,862-32,694
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income2,670-20,862-32,694
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares2,670-20,862-32,694